Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Carcinoma, Pancreatic Ductal"" wg kryterium: Temat


Tytuł :
Impact of Oncogenic Targets Controlled by Tumor-Suppressive miR-30a-5p in Pancreatic Ductal Adenocarcinoma.
Autorzy :
Nepal P; Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Hozaka Y; Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Tanaka T; Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Wada M; Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Asai S; Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba, Japan.
Minemura C; Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba, Japan.
Idichi T; Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Arigami T; Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Kurahara H; Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Seki N; Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba, Japan .
Ohtsuka T; Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Oct; Vol. 41 (10), pp. 4821-4836.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Pancreatic Ductal/*pathology
Genes, Tumor Suppressor/*physiology
Pancreatic Neoplasms/*pathology
Carcinoma, Pancreatic Ductal/genetics ; Carcinoma, Pancreatic Ductal/mortality ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Cell Transformation, Neoplastic/genetics ; Core Binding Factor beta Subunit/genetics ; Gene Expression Regulation, Neoplastic ; Humans ; Membrane Proteins/genetics ; MicroRNAs/genetics ; MicroRNAs/physiology ; Neoplasm Proteins/genetics ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/mortality ; Ribonucleoside Diphosphate Reductase/genetics ; Ribonucleoside Diphosphate Reductase/metabolism ; Survival Analysis
Czasopismo naukowe
Tytuł :
Clinical Predictors of Unresectable Disease at Laparotomy in Patients With Pancreatic Ductal Adenocarcinoma Planning to Undergo Surgical Resection.
Autorzy :
Shimizu T; Second Department of Surgery, Dokkyo Medical University, Tochigi, Japan .
Aoki T; Second Department of Surgery, Dokkyo Medical University, Tochigi, Japan.
Sato S; Second Department of Surgery, Dokkyo Medical University, Tochigi, Japan.
Matsumoto T; Second Department of Surgery, Dokkyo Medical University, Tochigi, Japan.
Shiraki T; Second Department of Surgery, Dokkyo Medical University, Tochigi, Japan.
Sakuraoka Y; Second Department of Surgery, Dokkyo Medical University, Tochigi, Japan.
Mori S; Second Department of Surgery, Dokkyo Medical University, Tochigi, Japan.
Iso Y; Second Department of Surgery, Dokkyo Medical University, Tochigi, Japan.
Ishizuka M; Second Department of Surgery, Dokkyo Medical University, Tochigi, Japan.
Kubota K; Second Department of Surgery, Dokkyo Medical University, Tochigi, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Oct; Vol. 41 (10), pp. 5171-5177.
Typ publikacji :
Journal Article
MeSH Terms :
Preoperative Care*
Adenocarcinoma/*pathology
CA-19-9 Antigen/*blood
Carcinoma, Pancreatic Ductal/*pathology
Laparotomy/*methods
Pancreatic Neoplasms/*pathology
Adenocarcinoma/blood ; Adenocarcinoma/surgery ; Aged ; Carcinoma, Pancreatic Ductal/blood ; Carcinoma, Pancreatic Ductal/surgery ; Female ; Follow-Up Studies ; Humans ; Male ; Pancreatic Neoplasms/blood ; Pancreatic Neoplasms/surgery ; Prognosis ; ROC Curve ; Retrospective Studies
SCR Disease Name :
Pancreatic Carcinoma
Czasopismo naukowe
Tytuł :
The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study.
Autorzy :
Du J; Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai, The People's Republic of China.
Gu J; Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai, The People's Republic of China.
Deng J; Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai, The People's Republic of China.
Kong L; Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai, The People's Republic of China.
Guo Y; Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai, The People's Republic of China.
Jin C; Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai, The People's Republic of China.
Bao Y; Department of Pathology, Huashan Hospital, Fudan University, Shanghai, The People's Republic of China.
Fu D; Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai, The People's Republic of China.
Li J; Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai, The People's Republic of China.
Pokaż więcej
Źródło :
Cancer investigation [Cancer Invest] 2021 Oct; Vol. 39 (9), pp. 741-755. Date of Electronic Publication: 2021 Aug 03.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*genetics
Carcinoma, Pancreatic Ductal/*genetics
Computational Biology/*methods
Glucose Transporter Type 1/*genetics
Pancreatic Neoplasms/*genetics
Aged ; Biomarkers, Tumor/metabolism ; Carcinoma, Pancreatic Ductal/metabolism ; Carcinoma, Pancreatic Ductal/therapy ; Female ; Gene Expression Profiling/methods ; Glucose Transporter Type 1/metabolism ; Humans ; Immunohistochemistry/methods ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multivariate Analysis ; Pancreatic Neoplasms/metabolism ; Pancreatic Neoplasms/therapy ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas.
Autorzy :
Safi SA; Department of Surgery (A), Medical Faculty, Heinrich-Heine-University and University Hospital Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany.
Fluegen G; Department of Surgery (A), Medical Faculty, Heinrich-Heine-University and University Hospital Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany.
Rehders A; Department of Surgery (A), Medical Faculty, Heinrich-Heine-University and University Hospital Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany.
Haeberle L; Institute of Pathology, Medical Faculty, Heinrich-Heine-University and University Hospital Dusseldorf, Dusseldorf, Germany.
Fung S; Department of Surgery (A), Medical Faculty, Heinrich-Heine-University and University Hospital Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany.
Keitel V; Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, Heinrich-Heine-University and University Hospital Dusseldorf, Dusseldorf, Germany.
Krieg A; Department of Surgery (A), Medical Faculty, Heinrich-Heine-University and University Hospital Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany.
Knoefel WT; Department of Surgery (A), Medical Faculty, Heinrich-Heine-University and University Hospital Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany. .
Lehwald-Tywuschik N; Department of Surgery (A), Medical Faculty, Heinrich-Heine-University and University Hospital Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany.
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2021 Oct; Vol. 26 (10), pp. 1911-1921. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*
Carcinoma, Pancreatic Ductal*/drug therapy
Carcinoma, Pancreatic Ductal*/surgery
Liver Neoplasms*/drug therapy
Liver Neoplasms*/surgery
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/surgery
Antineoplastic Combined Chemotherapy Protocols ; Female ; Humans ; Margins of Excision ; Neoplasm Recurrence, Local ; Pancreas ; Pancreatectomy
Czasopismo naukowe
Tytuł :
Preceding Systemic Chemotherapy for Patients with Pancreatic Ductal Adenocarcinoma with Positive Peritoneal Cytology Provides Survival Benefit Compared with Up-Front Surgery.
Autorzy :
Ariake K; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan. .
Mizuma M; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Motoi F; Department of Surgery I, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Maeda S; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Morikawa T; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ishida M; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ohtsuka H; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Aoki S; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Miura T; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Takadate T; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Nakagawa K; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kamei T; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Unno M; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2021 Oct; Vol. 28 (11), pp. 6246-6254. Date of Electronic Publication: 2021 Feb 20.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/drug therapy
Adenocarcinoma*/surgery
Carcinoma, Pancreatic Ductal*/drug therapy
Carcinoma, Pancreatic Ductal*/surgery
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/surgery
Humans ; Neoadjuvant Therapy ; Pancreatectomy ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
A case of intraductal papillary neoplasm of the bile duct accompanied by intraductal papillary mucinous neoplasm of the pancreas and hepatocellular carcinoma.
Autorzy :
Kitahama T; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan. .
Yamane H; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan.
Mohri K; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan.
Fukuoka E; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan.
Yoshida T; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan.
Yamagishi T; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan.
Goto H; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan.
Furutani A; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan.
Otsubo D; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan.
Matsumoto T; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan.
Tanaka M; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan.
Fujino Y; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan.
Tominaga M; Division of Gastroenterological Surgery, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi, Hyogo, 673-8558, Japan.
Pokaż więcej
Źródło :
Clinical journal of gastroenterology [Clin J Gastroenterol] 2021 Oct; Vol. 14 (5), pp. 1536-1543. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adenocarcinoma, Mucinous*/diagnostic imaging
Adenocarcinoma, Mucinous*/surgery
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Carcinoma, Pancreatic Ductal*/diagnostic imaging
Carcinoma, Pancreatic Ductal*/surgery
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/surgery
Aged ; Bile Ducts ; Humans ; Male ; Neoplasm Recurrence, Local ; Pancreas ; Pancreatectomy
Czasopismo naukowe
Tytuł :
Diffusion-weighted MR imaging in pancreatic ductal adenocarcinoma: prediction of next-generation sequencing-based tumor cellularity and prognosis after surgical resection.
Autorzy :
Jeon SK; Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Jang JY; Department of Surgery and Cancer Research Institute, Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul, 03080, Korea.
Kwon W; Department of Surgery and Cancer Research Institute, Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul, 03080, Korea.
Kim H; Department of Surgery and Cancer Research Institute, Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul, 03080, Korea.
Han Y; Department of Surgery and Cancer Research Institute, Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul, 03080, Korea.
Kim D; Department of Biological Sciences, College of Natural Sciences, Ajou University, Suwon, 16499, Republic of Korea.
Park D; Department of Biological Sciences, College of Natural Sciences, Ajou University, Suwon, 16499, Republic of Korea.
Kim JH; Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. .; Department of Radiology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. .
Pokaż więcej
Źródło :
Abdominal radiology (New York) [Abdom Radiol (NY)] 2021 Oct; Vol. 46 (10), pp. 4787-4799. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Pancreatic Ductal*/diagnostic imaging
Carcinoma, Pancreatic Ductal*/surgery
Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/surgery
Diffusion Magnetic Resonance Imaging ; High-Throughput Nucleotide Sequencing ; Humans ; Magnetic Resonance Imaging ; Neoplasm Recurrence, Local ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
High signal intensity on diffusion-weighted magnetic resonance images is a useful finding for detecting early-stage pancreatic cancer.
Autorzy :
Kurita A; Department of Gastroenterology and Hepatology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka, 530-8480, Japan. .; Department of Gastroenterology and Hepatology, Rakuwakai Otowa Hospital, 2 Otowachinji-cho, Yamashina-ku, Kyoto, 607-8062, Japan. .
Mori Y; Department of Gastroenterology and Hepatology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka, 530-8480, Japan.
Someya Y; Department of Diagnostic Imaging, Kitano Hospital, Tazuke Kofukai Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka, 530-8480, Japan.
Kubo S; Department of Diagnostic Imaging, Kitano Hospital, Tazuke Kofukai Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka, 530-8480, Japan.
Azuma S; Department of Gastroenterology and Hepatology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka, 530-8480, Japan.
Iwano K; Department of Gastroenterology and Hepatology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka, 530-8480, Japan.
Ikeda S; Department of Diagnostic Imaging, Kitano Hospital, Tazuke Kofukai Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka, 530-8480, Japan.
Okumura R; Department of Diagnostic Imaging, Kitano Hospital, Tazuke Kofukai Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka, 530-8480, Japan.
Yazumi S; Department of Gastroenterology and Hepatology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka, 530-8480, Japan.
Pokaż więcej
Źródło :
Abdominal radiology (New York) [Abdom Radiol (NY)] 2021 Oct; Vol. 46 (10), pp. 4817-4827. Date of Electronic Publication: 2021 Jul 05.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Carcinoma, Pancreatic Ductal*/diagnostic imaging
Carcinoma, Pancreatic Ductal*/surgery
Pancreatic Neoplasms*/diagnostic imaging
Humans ; Magnetic Resonance Imaging ; Pancreas ; Retrospective Studies
Czasopismo naukowe
Tytuł :
DeepPrognosis: Preoperative prediction of pancreatic cancer survival and surgical margin via comprehensive understanding of dynamic contrast-enhanced CT imaging and tumor-vascular contact parsing.
Autorzy :
Yao J; PAII Inc., Bethesda, MD 20817, USA. Electronic address: .
Shi Y; Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China.
Cao K; Department of Radiology, Changhai Hospital, Shanghai, China.
Lu L; PAII Inc., Bethesda, MD 20817, USA.
Lu J; Department of Radiology, Changhai Hospital, Shanghai, China.
Song Q; Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China.
Jin G; Department of Surgery, Changhai Hospital, Shanghai, China.
Xiao J; Ping An Technology, Shenzhen, China.
Hou Y; Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address: .
Zhang L; PAII Inc., Bethesda, MD 20817, USA.
Pokaż więcej
Źródło :
Medical image analysis [Med Image Anal] 2021 Oct; Vol. 73, pp. 102150. Date of Electronic Publication: 2021 Jun 29.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Pancreatic Ductal*/diagnostic imaging
Carcinoma, Pancreatic Ductal*/surgery
Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/surgery
Humans ; Margins of Excision ; Pancreas ; Prognosis ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.
Autorzy :
Del Poggetto E; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ho IL; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
Balestrieri C; Experimental Hematology Unit, San Raffaele Research Hospital, Milan 20132, Italy.; Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
Yen EY; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
Zhang S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Citron F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Shah R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
Corti D; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Diaferia GR; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan 20139, Italy.
Li CY; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
Loponte S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Carbone F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Hayakawa Y; Department of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY 10032, USA.
Valenti G; Department of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY 10032, USA.
Jiang S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sapio L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Jiang H; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Dey P; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Gao S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Deem AK; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Rose-John S; Department of Biochemistry, Christian-Albrechts-Universität zu Kiel, Kiel 24098, Germany.
Yao W; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ying H; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Rhim AD; Department of Gastroenterology Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Genovese G; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Heffernan TP; TRACTION, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Maitra A; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Wang TC; Department of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY 10032, USA.
Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Draetta GF; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Carugo A; TRACTION, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Natoli G; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan 20139, Italy.; Humanitas University, Pieve Emanuele, Milan 20089, Italy.
Viale A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Pokaż więcej
Źródło :
Science (New York, N.Y.) [Science] 2021 Sep 17; Vol. 373 (6561), pp. eabj0486. Date of Electronic Publication: 2021 Sep 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinogenesis*
Genes, ras*
Acinar Cells/*pathology
Carcinoma, Pancreatic Ductal/*pathology
Pancreas/*pathology
Pancreatitis/*physiopathology
Animals ; Carcinoma, Pancreatic Ductal/genetics ; Carcinoma, Pancreatic Ductal/immunology ; Carcinoma, Pancreatic Ductal/physiopathology ; Cell Transformation, Neoplastic ; Cells, Cultured ; Cellular Reprogramming ; Chromatin/metabolism ; Early Growth Response Protein 1/genetics ; Early Growth Response Protein 1/metabolism ; Enzyme Precursors/metabolism ; Epigenesis, Genetic ; Epithelial Cells/pathology ; Epithelial Cells/physiology ; Female ; MAP Kinase Signaling System ; Male ; Metaplasia ; Mice ; Mutation ; Pancreas/metabolism ; Pancreatitis/genetics ; Pancreatitis/immunology ; Spheroids, Cellular ; Transcriptome
Czasopismo naukowe
Tytuł :
Pancreatic Cancer: A Review.
Autorzy :
Park W; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; David M. Rubenstein Center for Pancreatic Cancer Research, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.; Parker Institute for Cancer Immunotherapy, San Francisco, California.
Chawla A; Department of Surgery, Northwestern Medicine Regional Medical Group, Northwestern University Feinberg School of Medicine, Chicago, Illinois.; Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois.
O'Reilly EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; David M. Rubenstein Center for Pancreatic Cancer Research, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Pokaż więcej
Źródło :
JAMA [JAMA] 2021 Sep 07; Vol. 326 (9), pp. 851-862.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Carcinoma, Pancreatic Ductal*/diagnosis
Carcinoma, Pancreatic Ductal*/epidemiology
Carcinoma, Pancreatic Ductal*/secondary
Carcinoma, Pancreatic Ductal*/therapy
Neoadjuvant Therapy*
Pancreatectomy*
Pancreatic Neoplasms*/diagnosis
Pancreatic Neoplasms*/epidemiology
Pancreatic Neoplasms*/pathology
Pancreatic Neoplasms*/therapy
Antineoplastic Agents/*therapeutic use
Combined Modality Therapy ; Early Detection of Cancer ; Humans ; Incidence
Czasopismo naukowe
Tytuł :
Pancreatic Ductal Adenocarcinoma Concomitant with Main Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Case Report.
Autorzy :
Yonamine K; Department of Gastroenterology, Sendai City Medical Center, Sendai, Miyagi, Japan.
Koshita S; Department of Gastroenterology, Sendai City Medical Center, Sendai, Miyagi, Japan.
Kanno Y; Department of Gastroenterology, Sendai City Medical Center, Sendai, Miyagi, Japan.
Ogawa T; Department of Gastroenterology, Sendai City Medical Center, Sendai, Miyagi, Japan.
Kusunose H; Department of Gastroenterology, Sendai City Medical Center, Sendai, Miyagi, Japan.
Sakai T; Department of Gastroenterology, Sendai City Medical Center, Sendai, Miyagi, Japan.
Miyamoto K; Department of Gastroenterology, Sendai City Medical Center, Sendai, Miyagi, Japan.
Kozakai F; Department of Gastroenterology, Sendai City Medical Center, Sendai, Miyagi, Japan.
Okano H; Department of Gastroenterology, Sendai City Medical Center, Sendai, Miyagi, Japan.
Okada T; Department of Gastroenterological Surgery, Sendai City Medical Center, Sendai, Miyagi, Japan.
Oikawa M; Department of Gastroenterological Surgery, Sendai City Medical Center, Sendai, Miyagi, Japan.
Tsuchiya T; Department of Gastroenterological Surgery, Sendai City Medical Center, Sendai, Miyagi, Japan.
Sawai T; Department of Pathology, Sendai City Medical Center, Sendai, Miyagi, Japan.
Noda Y; Department of Gastroenterology, Sendai City Medical Center, Sendai, Miyagi, Japan.; Department of Pathology, Sendai City Medical Center, Sendai, Miyagi, Japan.
Ito K; Department of Gastroenterology, Sendai City Medical Center, Sendai, Miyagi, Japan.
Pokaż więcej
Źródło :
The American journal of case reports [Am J Case Rep] 2021 Sep 02; Vol. 22, pp. e932565. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adenocarcinoma, Mucinous*/complications
Adenocarcinoma, Mucinous*/diagnosis
Adenocarcinoma, Mucinous*/surgery
Carcinoma, Pancreatic Ductal*/complications
Carcinoma, Pancreatic Ductal*/diagnosis
Carcinoma, Pancreatic Ductal*/surgery
Pancreatic Neoplasms*/complications
Pancreatic Neoplasms*/diagnosis
Aged ; Humans ; Male ; Pancreas ; Pancreatic Ducts
Czasopismo naukowe
Tytuł :
Preoperative diagnosis of multiple intraductal tubulopapillary neoplasms of the pancreas: dynamic imaging features from endoscopic ultrasound.
Autorzy :
Liu WH; Department of Gastroenterology and Hepatology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China.
Su XJ; Department of Gastroenterology, Changhai Hospital, Second Military Medical University and Naval Medical University, Shanghai, China.
Fang X; Department of Radiology, Changhai Hospital, Second Military Medical University and Naval Medical University, Shanghai, China.
Jiang H; Department of Pathology, Changhai Hospital, Second Military Medical University and Naval Medical University, Shanghai, China.
Guo SW; Department of General Surgery, Changhai Hospital, Second Military Medical University and Naval Medical University, Shanghai, China.
Wang KX; Department of Gastroenterology, Changhai Hospital, Second Military Medical University and Naval Medical University, Shanghai, China.
Pokaż więcej
Źródło :
Endoscopy [Endoscopy] 2021 Sep; Vol. 53 (9), pp. E345-E347. Date of Electronic Publication: 2020 Nov 11.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Pancreatic Ductal*/diagnostic imaging
Carcinoma, Pancreatic Ductal*/surgery
Pancreatic Neoplasms*/diagnostic imaging
Endosonography ; Humans ; Pancreas/diagnostic imaging
Czasopismo naukowe
Tytuł :
Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.
Autorzy :
Panda A; Department of Radiology, Mayo Clinic, 200 First St SW, Charlton 1, Rochester, MN 55905.
Garg I; Department of Radiology, Mayo Clinic, 200 First St SW, Charlton 1, Rochester, MN 55905.
Truty MJ; Department of Surgery, Mayo Clinic, Rochester, MN.
Kline TL; Department of Radiology, Mayo Clinic, 200 First St SW, Charlton 1, Rochester, MN 55905.
Johnson MP; Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.
Ehman EC; Department of Radiology, Mayo Clinic, 200 First St SW, Charlton 1, Rochester, MN 55905.
Suman G; Department of Radiology, Mayo Clinic, 200 First St SW, Charlton 1, Rochester, MN 55905.
Anaam DA; Department of Radiology, Mayo Clinic, 200 First St SW, Charlton 1, Rochester, MN 55905.
Kemp BJ; Department of Radiology, Mayo Clinic, 200 First St SW, Charlton 1, Rochester, MN 55905.
Johnson GB; Department of Radiology, Mayo Clinic, 200 First St SW, Charlton 1, Rochester, MN 55905.
Halfdanarson TR; Department of Medical Oncology, Mayo Clinic, Rochester, MN.
Venkatesh SK; Department of Radiology, Mayo Clinic, 200 First St SW, Charlton 1, Rochester, MN 55905.
Fidler JL; Department of Radiology, Mayo Clinic, 200 First St SW, Charlton 1, Rochester, MN 55905.
Goenka AH; Department of Radiology, Mayo Clinic, 200 First St SW, Charlton 1, Rochester, MN 55905.
Pokaż więcej
Źródło :
AJR. American journal of roentgenology [AJR Am J Roentgenol] 2021 Sep; Vol. 217 (3), pp. 730-740. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji :
Journal Article
MeSH Terms :
Fluorodeoxyglucose F18*
Adenocarcinoma/*diagnostic imaging
Carcinoma, Pancreatic Ductal/*diagnostic imaging
Magnetic Resonance Imaging/*methods
Neoadjuvant Therapy/*methods
Pancreatic Neoplasms/*diagnostic imaging
Tomography, X-Ray Computed/*methods
Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Carcinoma, Pancreatic Ductal/pathology ; Carcinoma, Pancreatic Ductal/therapy ; Female ; Humans ; Male ; Middle Aged ; Multimodal Imaging/methods ; Pancreas/diagnostic imaging ; Pancreas/pathology ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/therapy ; Predictive Value of Tests ; Retrospective Studies ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Coexisting Type 1 Autoimmune Pancreatitis and Mixed-type Intraductal Papillary Mucinous Neoplasm.
Autorzy :
Hirano K; Department of Internal Medicine, Japan Community Healthcare Organization Tokyo Takanawa Hospital, Japan.
Itoi T; Department of Internal Medicine, Japan Community Healthcare Organization Tokyo Takanawa Hospital, Japan.
Sasahira N; Department of Internal Medicine, Japan Community Healthcare Organization Tokyo Takanawa Hospital, Japan.
Koyama H; Department of Surgery, Japan Community Healthcare Organization Tokyo Takanawa Hospital, Japan.
Ihara F; Department of Pathology, Japan Community Healthcare Organization Tokyo Takanawa Hospital, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2021 Sep 01; Vol. 60 (17), pp. 2793-2797. Date of Electronic Publication: 2021 Mar 22.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Autoimmune Pancreatitis*
Carcinoma, Pancreatic Ductal*/complications
Carcinoma, Pancreatic Ductal*/diagnosis
Pancreatic Neoplasms*/complications
Pancreatic Neoplasms*/diagnosis
Aged, 80 and over ; Humans ; Immunoglobulin G ; Male ; Pancreas ; Pancreatic Ducts
Czasopismo naukowe
Tytuł :
Radiomics model of dual-time 2-[ F]FDG PET/CT imaging to distinguish between pancreatic ductal adenocarcinoma and autoimmune pancreatitis.
Autorzy :
Liu Z; School of Biomedical Engineering (Suzhou), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China.; Department of Medical Imaging, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, 88 Keling Road, Suzhou, 215163, China.
Li M; Department of Medical Imaging, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, 88 Keling Road, Suzhou, 215163, China.
Zuo C; Department of Nuclear Medicine, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai, 200433, China.
Yang Z; Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
Yang X; Wenzhou People's Hospital, Wenzhou Medical University, Wenzhou, 325041, China.
Ren S; Department of Nuclear Medicine, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai, 200433, China.
Peng Y; Department of Nuclear Medicine, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai, 200433, China.
Sun G; Department of Nuclear Medicine, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai, 200433, China.
Shen J; Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
Cheng C; Department of Nuclear Medicine, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai, 200433, China. .
Yang X; Department of Medical Imaging, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, 88 Keling Road, Suzhou, 215163, China. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2021 Sep; Vol. 31 (9), pp. 6983-6991. Date of Electronic Publication: 2021 Mar 06.
Typ publikacji :
Journal Article
MeSH Terms :
Autoimmune Pancreatitis*
Carcinoma, Pancreatic Ductal*/diagnostic imaging
Pancreatic Neoplasms*/diagnostic imaging
Diagnosis, Differential ; Fluorodeoxyglucose F18 ; Humans ; Positron Emission Tomography Computed Tomography ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer.
Autorzy :
Arscott WT; Departments of Radiation Oncology.; Compass Oncology, Tigard, OR.
Nead KT; Departments of Radiation Oncology.; The University of Texas MD Anderson Cancer Center, Houston, TX.
Bear A; Medical Oncology.
Venigalla S; Departments of Radiation Oncology.
Shabason J; Departments of Radiation Oncology.
Lukens JN; Departments of Radiation Oncology.
Plastaras JP; Departments of Radiation Oncology.
Wojcieszynski A; Departments of Radiation Oncology.
Metz J; Departments of Radiation Oncology.
O'Hara M; Medical Oncology.
Reiss KA; Medical Oncology.
Teitelbaum U; Medical Oncology.
Loaiza-Bonilla A; Medical Oncology.; Cancer Treatment Centers of America, Philadelphia, PA.
Drebin J; Surgery, University of Pennsylvania.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Lee MK 4th; Surgery, University of Pennsylvania.
Shroff SG; Pathology.
Ben-Josef E; Departments of Radiation Oncology.
Pokaż więcej
Źródło :
American journal of clinical oncology [Am J Clin Oncol] 2021 Sep 01; Vol. 44 (9), pp. 469-474.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Albumins/*therapeutic use
Carcinoma, Pancreatic Ductal/*radiotherapy
Paclitaxel/*therapeutic use
Pancreatic Neoplasms/*radiotherapy
Radiation-Sensitizing Agents/*therapeutic use
Aged ; Aged, 80 and over ; Albumins/adverse effects ; Carcinoma, Pancreatic Ductal/drug therapy ; Carcinoma, Pancreatic Ductal/mortality ; Carcinoma, Pancreatic Ductal/surgery ; Chemoradiotherapy ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Female ; Fluorouracil/therapeutic use ; Humans ; Male ; Middle Aged ; Paclitaxel/adverse effects ; Pancreatic Neoplasms/drug therapy ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/surgery ; Radiation-Sensitizing Agents/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Refining pancreatic ductal adenocarcinoma molecular subtype and precision therapeutics with single-nucleus RNA-seq.
Autorzy :
He L; Department of Pharmacology & Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA. .
Pokaż więcej
Źródło :
BMC medicine [BMC Med] 2021 Aug 18; Vol. 19 (1), pp. 182. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Pancreatic Ductal*/drug therapy
Carcinoma, Pancreatic Ductal*/genetics
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Biomarkers, Tumor ; Humans ; RNA-Seq
Czasopismo naukowe
Tytuł :
Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma.
Autorzy :
Ahmed A; Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany.; Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Köhler S; Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany.
Klotz R; General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany.
Giese N; General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany.
Lasitschka F; Institute of Pathology, University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany.
Hackert T; General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany.
Springfeld C; Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany.
Zörnig I; Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany.
Jäger D; Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany.; Applied Tumor Immunity Clinical Cooperation Unit, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Halama N; Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, University Heidelberg, Heidelberg, Germany.; Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pokaż więcej
Źródło :
Oncoimmunology [Oncoimmunology] 2021 Aug 10; Vol. 10 (1), pp. 1962135. Date of Electronic Publication: 2021 Aug 10 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Pancreatic Ductal*/blood
Carcinoma, Pancreatic Ductal*/diagnosis
Carcinoma, Pancreatic Ductal*/surgery
Pancreatic Neoplasms*/blood
Pancreatic Neoplasms*/diagnosis
Pancreatic Neoplasms*/surgery
Interleukin-2/*blood
Macrophage Migration-Inhibitory Factors/*blood
Humans ; Intramolecular Oxidoreductases ; Prognosis ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Neutrophil in the Pancreatic Tumor Microenvironment.
Autorzy :
Jin L; Department of Pathology & Clinical Labs, Rogel Cancer Center and Center for RNA Biomedicine, University of Michigan, Ann Arbor, MI 48109, USA.
Kim HS; Department of Pathology & Clinical Labs, Rogel Cancer Center and Center for RNA Biomedicine, University of Michigan, Ann Arbor, MI 48109, USA.
Shi J; Department of Pathology & Clinical Labs, Rogel Cancer Center and Center for RNA Biomedicine, University of Michigan, Ann Arbor, MI 48109, USA.
Pokaż więcej
Źródło :
Biomolecules [Biomolecules] 2021 Aug 07; Vol. 11 (8). Date of Electronic Publication: 2021 Aug 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Antineoplastic Agents, Immunological/*therapeutic use
Carcinogenesis/*drug effects
Carcinoma, Pancreatic Ductal/*immunology
Neutrophils/*immunology
Pancreatic Neoplasms/*immunology
Tumor Microenvironment/*drug effects
Carcinogenesis/genetics ; Carcinogenesis/immunology ; Carcinogenesis/pathology ; Carcinoma, Pancreatic Ductal/drug therapy ; Carcinoma, Pancreatic Ductal/genetics ; Carcinoma, Pancreatic Ductal/mortality ; Cell Communication/drug effects ; Cytokines/genetics ; Cytokines/immunology ; Fibroblasts/drug effects ; Fibroblasts/immunology ; Fibroblasts/pathology ; Gene Expression Regulation, Neoplastic ; Humans ; Intercellular Signaling Peptides and Proteins/genetics ; Intercellular Signaling Peptides and Proteins/immunology ; Neutrophil Infiltration/drug effects ; Neutrophils/drug effects ; Neutrophils/pathology ; Pancreatic Neoplasms/drug therapy ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/mortality ; Prognosis ; Receptors, Cytokine/genetics ; Receptors, Cytokine/immunology ; Survival Analysis ; T-Lymphocytes/drug effects ; T-Lymphocytes/immunology ; T-Lymphocytes/pathology ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies